Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe

AIDS Research and Human Retroviruses

Volumn 15, Issue 1, 1999, Pages 65-69

  Shafer, Robert W ^a,b   Chuang, Teddy K ^a   Hsu, Philip ^a   White, Camille Bodley ^a   Katzenstein, David A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; DRUG SENSITIVITY; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROCONVERSION; UNINDEXED SEQUENCE; VIRUS GENOME; ZIMBABWE;

ADULT; AMINO ACID SEQUENCE; FEMALE; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; ZIMBABWE;

EID: 0032904487     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311727     Document Type: Article

References (23)

1. Korber B, Theiler J, and Wolinsky S: Limitations of a molecular clock applied to considerations of the origin of HIV-1. Science 1998;280:1868-1871.
2. Alaeus A, Leitner T, Lidman K, and Albert J: Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
3. Hu DJ, Dondero TJ, Rayfield MA, George RJ, Schoochetman G, Jaffe HW, Luo CC, Kalish ML, Weniger BG, Pau CP, Schable CA, and Curran JW: The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 1996;275:210-216.
4. Cornelissen M, van der Burg R, Zorgdrager F, Lukashov V, and Goudsmit J: pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. J Virol 1997;71:6348-6358.
5. Janini LM, Tanuri A, Schechter M, Peralta JM, Vicente ACP, Dela Torre N, Pieniazek NJ, Luo CC, Ramos A, Soriano V, Schochetman G, Rayfield MA, and Pieniazek D: Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 1998;177:227-231.
6. Arnold C, Barlow KL, Parry JV, and Clewley JP: At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. AIDS Res Hum Retroviruses 1995;11:427-429.
7. Benson DA, Bogusku MS, Lipman DJ, Ostell J, and Ouellette BF: GenBank. Nucleic Acids Res 1998;26:1-7.
8. Korber B, Foley B, Leitner T, McCutchan F, Hahn B, Mellors JW, Myers G, and Kuiken C: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1997.
9. Salminen MO, Johansson B, Sonnerborg A, Ayehunie S, Gotte D, Leinikki P, Burke DS, and McCutchan FE: Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses 1996; 12:1329-1339.
10. Mbizvo MT, Machekano R, McFarland W, Ray S, Bassett M, Latif A, and Katzenstein D: HIV seroincidence and correlate of seroconversion in a cohort of male factory workers in Harare, Zimbabwe. AIDS 1996;10:895-901.
11. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, and Essex M: Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997;71:8657-8665.
12. Shafer RW, Eisen JA, Merigan TC, and Katzenstein DA: Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe. J Virol 1997;71:5441-5448.
13. Felsenstein J: PHYLIP (Phylogeny Inference Package), version 3.5. University of Washington, Seattle, Washington, 1993.
14. Gao F, Robertson DL, Carruthers CD, Morrison SG, Jian B, Chen Y, Barré-Sinoussi F, Girard M, Srinivasan A, Abimiku AG, Shaw GM, Sharp PM, and Hahn BH: A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998; 72:5680-5698.
15. Carr JK, Salminen MO, Albert J, Sanders-Buell E, Gotte D, Birx DL, and McCutchan FE: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinans. Virology 1998;247:22-31.
16. Dietrich U, Grez M, von Briesen H, Panhans B, Geibendorfer M, Kuhnel H, Maniar J, Mahambre G, Becker WB, Becker ML, and Rübsamen-Waigmann H: HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS 1993;7:23-27.
17. Soto-Ramirez LE, Tripathy S, Renjifo B, and Essex M: HIV-1 pol sequences from India fit distinct subtype pattern. J Acquir Immune Defic Syndr Hum Retroviral 1996;13:299-307.
18. Shafer RW, Stevenson D, and Chan B: Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res (in press, January 1999).
19. Shafer RW, Winters MA, Palmer S, and Merigan TC: Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. Ann Intern Med 1998;128:906-911.
20. Palmer S, Alaeus A, Albert J, and Cox S: Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses 1998;14:157-162.
21. Apetrei C, Descamps D, Collin G, Loussert-Ajaka, Damond F, Duca M, Simon F, and Brun-Vezinet FB: Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol 1998;72:3534-3538.
22. Descamps D, Apetrei C, Collin G, Damond F, Simon F, and Brun-Vezinet F: Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS 1998;12:1109-1111. [Letter]
23. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, and Brun-Vezinet F: Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. J Virol 1997;71:8893-8898.